Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia
- PMID: 12460345
- DOI: 10.1046/j.1464-410x.2002.03031.x
Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia
Abstract
Objective: To compare the efficacy and frequency of complications of transurethral interstitial laser coagulation (ILC) and transurethral microwave thermotherapy (TUMT) with transurethral resection or incision of the prostate (TURP/TUIP) in patients with symptomatic benign prostatic hyperplasia (BPH).
Patients and methods: Forty-eight patients were randomized to undergo ILC, 46 to TUMT and 24 to TURP/TUIP; they were followed for 6 months and the outcome analysed on an intention-to-treat basis.
Results: At 6 months the symptom scores and maximum urinary flow rate (Qmax) had improved significantly in all groups. At 6 months the mean symptom score was 9.2 in both experimental groups and 6.8 in the control group (P > 0.05); the mean Qmax was 20.6 mL/s in the control group, 16.2 in the ILC group (P > 0.05 vs control) and 13.2 in the TUMT group (P < 0.05 vs. the control group). In the TUMT group patients developing urinary retention afterward had a significantly greater increase in Qmax than those who did not. The types of complications in the three groups varied. Urinary tract infection occurred frequently in the experimental groups, especially after ILC, whereas the 'well-known' complications of TURP occurred in the control group. Overall, 36% in the ILC, 54% in the TUMT and 73% in the control group had no complications (retrograde ejaculation excluded) during the first 6 months. One patient in the TUMT group underwent TURP after 3 months, whereas no patients in the ILC or the con-trol group were re-treated for BPH within the first 6 months.
Conclusion: In the short term both ILC and TUMT are reasonable alternatives to standard transurethral surgery for symptomatic BPH, where the reduction of symptoms is the primary goal of treatment. However, both ILC and TUMT were associated with morbidity, although the complication profiles differed from those after TURP/TUIP. Both ILC and TUMT seem advantageous in some patients because of the reduced risk of bleeding and the eliminated risk of TUR syndrome, and because TUMT only requires local anaesthesia. Thus, as neither treatment is better in all aspects, the advantages of one technique over the other must be weighed when deciding how to treat each patient.
Comment in
-
Transurethral interstitial laser coagulation of the prostate and transurethral microwave thermotherapy vs transurethral resection or incision of the prostate: results of a randomized, controlled study in patients with symptomatic benign prostatic hyperplasia.J Urol. 2003 Jul;170(1):342-3. J Urol. 2003. PMID: 14567352 No abstract available.
Similar articles
-
Microwave thermotherapy for benign prostatic hyperplasia.Cochrane Database Syst Rev. 2007 Oct 17;(4):CD004135. doi: 10.1002/14651858.CD004135.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2012 Sep 12;(9):CD004135. doi: 10.1002/14651858.CD004135.pub3. PMID: 17943811 Updated.
-
Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.Cochrane Database Syst Rev. 2021 Jun 28;6(6):CD004135. doi: 10.1002/14651858.CD004135.pub4. Cochrane Database Syst Rev. 2021. PMID: 34180047 Free PMC article.
-
Cost-effectiveness of new treatments for benign prostatic hyperplasia: results of a randomized trial comparing the short-term cost-effectiveness of transurethral interstitial laser coagulation of the prostate, transurethral microwave thermotherapy and standard transurethral resection or incision of the prostate.Scand J Urol Nephrol. 2002;36(4):286-95. doi: 10.1080/003655902320248263. Scand J Urol Nephrol. 2002. PMID: 12201922 Clinical Trial.
-
Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.Ont Health Technol Assess Ser. 2006;6(17):1-121. Epub 2006 Aug 1. Ont Health Technol Assess Ser. 2006. PMID: 23074487 Free PMC article.
-
Transurethral microwave thermotherapy (Prostatron version 2.5) compared with transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a randomized, controlled, parallel study.Br J Urol. 1997 Feb;79(2):181-5. doi: 10.1046/j.1464-410x.1997.02667.x. Br J Urol. 1997. PMID: 9052467 Clinical Trial.
Cited by
-
Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?World J Urol. 2006 Sep;24(4):389-96. doi: 10.1007/s00345-006-0098-7. Epub 2006 Jun 3. World J Urol. 2006. PMID: 16752156 Review.
-
Lasers for lower urinary tract symptoms secondary to benign prostatic hyperplasia: when is the fuss worth it?Curr Urol Rep. 2005 Jul;6(4):257-62. doi: 10.1007/s11934-005-0018-1. Curr Urol Rep. 2005. PMID: 15978224 Review.
-
Transurethral Microwave Thermotherapy for Benign Prostatic Hyperplasia: An Updated Cochrane Review.World J Mens Health. 2022 Jan;40(1):127-138. doi: 10.5534/wjmh.210115. Epub 2021 Aug 4. World J Mens Health. 2022. PMID: 34448377 Free PMC article.
-
Non-inferiority, randomised, open-label clinical trial on the effectiveness of transurethral microwave thermotherapy compared to prostatic artery embolisation in reducing severe lower urinary tract symptoms in men with benign prostatic hyperplasia: study protocol for the TUMT-PAE-1 trial.Trials. 2024 Sep 2;25(1):574. doi: 10.1186/s13063-024-08409-x. Trials. 2024. PMID: 39223593 Free PMC article.
-
Medical therapy versus surgery and minimally invasive surgical therapies for lower urinary tract symptoms and benign prostatic hyperplasia: what makes better economic sense?Curr Urol Rep. 2007 Jul;8(4):289-97. doi: 10.1007/s11934-007-0075-8. Curr Urol Rep. 2007. PMID: 18519013
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical